Page last updated: 2024-08-24

aripiprazole and Anxiety

aripiprazole has been researched along with Anxiety in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (25.00)29.6817
2010's14 (58.33)24.3611
2020's4 (16.67)2.80

Authors

AuthorsStudies
Bojarski, AJ; Bucki, A; Byrtus, H; Czopek, A; Kalinowska-Tłuścik, J; Kazek, G; Kołaczkowski, M; Partyka, A; Pawłowski, M; Piaskowska, A; Wesołowska, A1
Alda, M; Beaulieu, S; Berk, M; Bond, DJ; Calabrese, J; Chakrabarty, T; Frey, BN; Goldstein, BI; Kanba, S; Kapczinski, F; Kauer-Sant'Anna, M; Kennedy, SH; Kozicky, JM; Lam, RW; Malhi, G; McIntyre, RS; Milev, RV; O'Donovan, C; Parikh, SV; Post, R; Ravindran, AV; Rej, S; Schaffer, A; Sharma, V; Suppes, T; Tourjman, V; Vazquez, G; Vieta, E; Yatham, LN1
Kiss, A; Koprdova, R; Mach, M; Osacka, J; Tillinger, A1
Baldisserotto, B; Barcellos, HHA; Barcellos, LJG; Fernandes, M; Kirsten, K; Koakoski, G; Maffi, VC; Mendonça-Soares, S; Pompermaier, A1
Cardiel-Sam, H; Shirk, DV; Wendel, N; Williams, SD1
Adham, N; Banasr, M; Duman, RS; Duric, V; Franklin, T; Gyertyán, I; Kiss, B; Lepack, A1
Baker, RA; Dunlop, BW; Eudicone, JM; McCabe, B; Sheehan, JJ1
De Santis, M; Deng, C; Huang, XF; Lian, J1
Giermaziak, W; Kus, K; Nowakowska, E; Ratajczak, P1
Taylor, WD1
Aizenstein, HJ; Anderson, SJ; Blumberger, D; Butters, MA; Dew, MA; Diniz, BS; Kaneriya, SH; Karp, JF; Lenze, EJ; Lotrich, F; Mulsant, BH; Reynolds, CF; Robbins-Welty, GA; Smagula, SF1
Bieńkowski, P; Jastrzębska-Więsek, M; Kołaczkowski, M; Mierzejewski, P; Partyka, A; Wasik, A; Wesołowska, A1
Abe, M; Egashira, N; Fujiwara, M; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Oishi, R; Okuno, R1
Bellino, S; Bogetto, F; Paradiso, E1
Evenden, J; Jonak, G; Ross, L; Zhou, J1
Biojone, C; Casarotto, PC; Guimarães, FS; Moreira, FA; Resstel, LB; Zangrossi, H1
Aung, GL; Kawamoto, LS; O'Brien, JG; Tien, PG1
Katzman, MA1
Burda, K; Czubak, A; Kus, K; Nowakowska, E; Ratajczak, P; Zin, J1
Cavanna, AE; Rickards, H; Worrall, R1
Kurokawa, K; Mizuno, K; Ohkuma, S; Shibasaki, M1
Kasper, S; Winkler, D1
Amoretti, A; Di Lorenzo, R; Fiorini, F; Forghieri, M; Genedani, S; Rigatelli, M1

Reviews

2 review(s) available for aripiprazole and Anxiety

ArticleYear
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.
    Bipolar disorders, 2021, Volume: 23, Issue:8

    Topics: Antipsychotic Agents; Anxiety; Aripiprazole; Bipolar Disorder; Canada; Humans; Olanzapine; Valproic Acid

2021
Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
    Journal of affective disorders, 2011, Volume: 128 Suppl 1

    Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Anxiety Disorders; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Mental Disorders; Piperazines; Quinolones

2011

Trials

1 trial(s) available for aripiprazole and Anxiety

ArticleYear
Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    JAMA psychiatry, 2016, Volume: 73, Issue:4

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Aripiprazole; Comorbidity; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Executive Function; Female; Follow-Up Studies; Humans; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Set, Psychology; Severity of Illness Index; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride

2016

Other Studies

21 other study(ies) available for aripiprazole and Anxiety

ArticleYear
Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.
    Bioorganic & medicinal chemistry, 2015, Jul-01, Volume: 23, Issue:13

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Depression; Dextroamphetamine; Hydantoins; Hyperkinesis; Imidazolidines; Male; Mice; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Swimming

2015
Haloperidol and aripiprazole affects CRH system and behaviour of animals exposed to chronic mild stress.
    Neurochemistry international, 2022, Volume: 152

    Topics: Amygdala; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Corticotropin-Releasing Hormone; Haloperidol; Male; Paraventricular Hypothalamic Nucleus

2022
Aripiprazole prevents stress-induced anxiety and social impairment, but impairs antipredatory behavior in zebrafish.
    Pharmacology, biochemistry, and behavior, 2020, Volume: 189

    Topics: Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Cichlids; Female; Food Chain; Goldfish; Male; Predatory Behavior; Social Behavior; Stress, Physiological; Water Pollution, Chemical; Zebrafish

2020
    Journal of child and adolescent psychopharmacology, 2021, Volume: 31, Issue:5

    Topics: Angioedema; Antidepressive Agents; Anxiety; Aripiprazole; Black or African American; Child; Diphenhydramine; Histamine H1 Antagonists; Humans; Male; Nausea; Neck Pain

2021
Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model.
    The international journal of neuropsychopharmacology, 2017, 10-01, Volume: 20, Issue:10

    Topics: Anhedonia; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Aripiprazole; Chronic Disease; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Imipramine; Male; Mice, Inbred C57BL; Mice, Knockout; Piperazines; Receptors, Dopamine D3; Stress, Psychological; Uncertainty

2017
How well do clinicians and patients agree on depression treatment outcomes? Implications for personalized medicine.
    Human psychopharmacology, 2014, Volume: 29, Issue:6

    Topics: Adult; Antidepressive Agents; Anxiety; Aripiprazole; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Precision Medicine; Prognosis; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Self Report; Treatment Outcome

2014
Early antipsychotic treatment in childhood/adolescent period has long-term effects on depressive-like, anxiety-like and locomotor behaviours in adult rats.
    Journal of psychopharmacology (Oxford, England), 2016, Volume: 30, Issue:2

    Topics: Age Factors; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Depression; Female; Male; Motor Activity; Olanzapine; Rats; Rats, Sprague-Dawley; Risperidone; Sex Factors; Time Factors

2016
The influence of aripiprazole and olanzapine on the anxiolytic-like effect observed in prenatally stressed rats (animal model of schizophrenia) exposed to the ethyl alcohol.
    Pharmacological reports : PR, 2016, Volume: 68, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Disease Models, Animal; Ethanol; Female; Male; Olanzapine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Schizophrenia; Stress, Psychological

2016
Moderators of Remission in Patients With Late-Life Depression: Where Do We Go Next?
    JAMA psychiatry, 2016, Volume: 73, Issue:4

    Topics: Antipsychotic Agents; Anxiety; Aripiprazole; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Executive Function; Female; Humans; Male; Set, Psychology

2016
ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety.
    Naunyn-Schmiedeberg's archives of pharmacology, 2016, Volume: 389, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Conditioning, Psychological; Conflict, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Isoxazoles; Male; Maze Learning; Mice; Motor Activity; Olanzapine; Punishment; Rats, Wistar; Reaction Time; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Sulfonamides

2016
Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
    European journal of pharmacology, 2008, Sep-11, Volume: 592, Issue:1-3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Catalepsy; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Indoles; Ketanserin; Male; Mice; Mice, Inbred ICR; Olanzapine; Piperazines; Piperidines; Postural Balance; Psychomotor Performance; Pyridines; Quinolones; Quinpirole; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Serotonin Antagonists; Serotonin Receptor Agonists

2008
Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
    Psychiatry research, 2008, Nov-30, Volume: 161, Issue:2

    Topics: Adult; Ambulatory Care; Antipsychotic Agents; Anxiety; Aripiprazole; Borderline Personality Disorder; Diagnostic and Statistical Manual of Mental Disorders; Drug Resistance; Drug Therapy, Combination; Headache; Humans; Middle Aged; Personality Inventory; Piperazines; Psychiatric Status Rating Scales; Quinolones; Sertraline; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome

2008
A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs.
    Behavioural pharmacology, 2009, Volume: 20, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Aripiprazole; Benzodiazepines; Chlordiazepoxide; Conditioning, Operant; Conflict, Psychological; Dextroamphetamine; Diazepam; Electroshock; Flumazenil; Male; Piperazines; Punishment; Pyridazines; Quinolones; Rats; Rats, Sprague-Dawley; Triazoles; Yohimbine

2009
Anti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxiety.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Male; Maze Learning; Motor Activity; Piperazines; Quinolones; Rats; Rats, Wistar

2011
Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir.
    The Annals of pharmacotherapy, 2010, Volume: 44, Issue:11

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Cytochrome P-450 Enzyme Inhibitors; Darunavir; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; HIV Infections; HIV Protease Inhibitors; Humans; Male; Piperazines; Quinolones; Ritonavir; Sulfonamides; Thiophenes

2010
Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats.
    Pharmacological reports : PR, 2011, Volume: 63, Issue:4

    Topics: Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Cognition; Depression; Disease Models, Animal; Male; Maze Learning; Memory; Piperazines; Quinolones; Rats; Rats, Wistar; Toxicity Tests

2011
Treatment practices in Tourette syndrome: the European perspective.
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2012, Volume: 16, Issue:4

    Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome

2012
Effect of aripiprazole on anxiety associated with ethanol physical dependence and on ethanol-induced place preference.
    Journal of pharmacological sciences, 2012, Volume: 118, Issue:2

    Topics: Alcoholism; Animals; Antipsychotic Agents; Anxiety; Aripiprazole; Behavior, Animal; Dopamine; Ethanol; Male; Mice; Piperazines; Pyridines; Quinolones; Substance Withdrawal Syndrome; Time Factors

2012
Aripiprazole (Abilify) for schizophrenia.
    The Medical letter on drugs and therapeutics, 2003, Feb-17, Volume: 45, Issue:1150

    Topics: Antipsychotic Agents; Anxiety; Aripiprazole; Dopamine Agonists; Drug Interactions; Fees, Pharmaceutical; Humans; Intestinal Absorption; Nausea; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Therapeutic Equivalency

2003
European College of Neuropsychopharmacology - 16th Congress. 20-24 September 2003, Prague, Czech Republic.
    IDrugs : the investigational drugs journal, 2003, Volume: 6, Issue:11

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Anxiety; Aripiprazole; Dopamine Antagonists; Humans; Nicotinic Agonists; Piperazines; Psychotropic Drugs; Quinolones; Receptors, Metabotropic Glutamate; Receptors, Nicotinic; Schizophrenia

2003
Aripiprazole: effectiveness and safety under naturalistic conditions.
    Experimental and clinical psychopharmacology, 2007, Volume: 15, Issue:6

    Topics: Adult; Antipsychotic Agents; Anxiety; Aripiprazole; Female; Humans; Inpatients; Italy; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Recurrence; Retrospective Studies; Schizoid Personality Disorder; Schizophrenia, Paranoid; Schizotypal Personality Disorder; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome

2007